FRI0122 Drug survival of adalimumab in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis over 10 years in real-world setting of czech registry attra

2018 ◽  
Author(s):  
K. Pavelka ◽  
J. Zavada ◽  
Z. Kristkova ◽  
L. Szczukova
Keyword(s):  
Rheumatoid Arthritis ◽  
Psoriatic Arthritis ◽  
Ankylosing Spondylitis ◽  
Real World ◽  
Drug Survival ◽  
Real World Setting

scholarly journals PBI89 PHARMACOUTILIZATION OF BIOLOGICAL DRUGS IN PATIENTS AFFECTED BY PSORIASIS, PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS IN AN ITALIAN REAL-WORLD SETTING

2019 ◽  
Vol 22 ◽  
pp. S434
Author(s):  
D. Colombo ◽  
E. Zagni ◽  
V. Perrone ◽  
D. Sangiorgi ◽  
M. Andretta ◽  
...  
Keyword(s):  
Psoriatic Arthritis ◽  
Ankylosing Spondylitis ◽  
Real World ◽  
Biological Drugs ◽  
Real World Setting

scholarly journals Real-world evidence of the impact of adalimumab on work productivity and sleep measures in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis

2020 ◽  
Vol 12 ◽  
pp. 1759720X2094908
Author(s):  
Maria G. Tektonidou ◽  
Gkikas Katsifis ◽  
Athanasios Georgountzos ◽  
Athina Theodoridou ◽  
Eftychia-Maria Koukli ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Psoriatic Arthritis ◽  
Ankylosing Spondylitis ◽  
Disease Activity ◽  
Real World ◽  
Sleep Problems ◽  
Work Productivity ◽  
Routine Care ◽  
Activity Impairment ◽  
Work Impairment

Objective: Our aim was to evaluate the effect of adalimumab on work productivity measures, overall activity impairment, and sleep quality in patients with active moderate to severe rheumatoid arthritis (RA), psoriatic arthritis (PsA), or ankylosing spondylitis (AS) treated in routine care settings in Greece and determine factors associated with work impairment and sleep disturbance. Methods: Patients with active moderate to severe RA ( n = 184), PsA ( n = 166), and AS ( n = 150) were enrolled in this 24-month, prospective, observational study at 80 hospital outpatient clinics and private practices throughout Greece. Patients received adalimumab alone or in combination with standard antirheumatic therapies according to routine care. Work productivity and sleep were assessed through two patient-reported outcome measures: the Work Productivity and Activity Impairment–General Health questionnaire and the Medical Outcomes Study Sleep Scale (MOS-SS). Pearson correlation coefficients were estimated to assess the association of work impairment and sleep disturbances with disease activity scores. Results: In the overall population, adalimumab significantly lowered absenteeism [mean (95% confidence interval) reduction, 18.9% (13.3–24.5%); n = 100]; presenteeism [40.0% (33.8–46.3%); n = 98], overall work productivity impairment [46.8% (40.4–53.2%); n = 94], activity impairment [47.0% (44.3–49.6); n = 421], and the MOS-SS sleep problems index [31.6 (29.5–34.1); n = 421] after 24-month treatment ( p < 0.001). Significant improvements were also noted across the RA, PsA, and AS subpopulations ( p < 0.05). Improvements in overall work impairment and sleep disturbance positively correlated with improvements in disease activity measures. Conclusion: Adalimumab improves work productivity and sleep problems while lowering disease activity in patients with moderate to severe RA, PsA, and AS managed in real-world settings.

Pharmaco-utilization of biologic drugs in patients affected by psoriasis, psoriatic arthritis and ankylosing spondylitis in an Italian real-world setting

2020 ◽  
Vol 20 (5) ◽  
pp. 491-497
Author(s):  
Emanuela Zagni ◽  
Delia Colombo ◽  
Martina Fiocchi ◽  
Valentina Perrone ◽  
Diego Sangiorgi ◽  
...  
Keyword(s):  
Psoriatic Arthritis ◽  
Ankylosing Spondylitis ◽  
Real World ◽  
Biologic Drugs ◽  
Real World Setting

scholarly journals AB0785 DRUG SURVIVAL OF SECUKINUMAB FOR PSORIATIC ARTHRITIS IN A REAL-WORLD SETTING

2019 ◽  
Author(s):  
Marta Valero ◽  
Beatriz Joven-Ibáñez ◽  
María Martín ◽  
Jose Campos Esteban ◽  
Carolina Merino Argumánez ◽  
...  
Keyword(s):  
Psoriatic Arthritis ◽  
Real World ◽  
Drug Survival ◽  
Real World Setting

AB0302 Profile of Joint Involvement over Time in Rheumatoid Arthritis and Psoriatic Arthritis Patients Treated with Anti-TNF in A Real-World Setting

2014 ◽  
Vol 73 (Suppl 2) ◽  
pp. 904.2-905
Author(s):  
A. Jovaisas ◽  
M. Starr ◽  
D. Choquette ◽  
M. Zummer ◽  
R. Arendse ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Psoriatic Arthritis ◽  
Real World ◽  
Joint Involvement ◽  
Real World Setting ◽  
Over Time

scholarly journals Secukinumab Use in Patients with Moderate to Severe Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis in Real-World Setting in Europe: Baseline Data from SERENA Study

2020 ◽  
Vol 37 (6) ◽  
pp. 2865-2883 ◽  
Author(s):  
Uta Kiltz ◽  
Petros P. Sfikakis ◽  
Karl Gaffney ◽  
Paul-Gunther Sator ◽  
Ralph von Kiedrowski ◽  
...  
Keyword(s):  
Psoriatic Arthritis ◽  
Ankylosing Spondylitis ◽  
Real World ◽  
Severe Psoriasis ◽  
Baseline Data ◽  
Real World Setting
Sign in / Sign up

Export Citation Format

Share Document